Good’s syndrome, a rare form of acquired immunodeficiency associated with thymomas

• Main Authors: Antonio Tamburello, Laura Castelnovo, Paola Faggioli, Daniela Bompane, Bruno Brando, Arianna Gatti, Lucia Roncoroni, Biancamaria Di Marco, Antonino Mazzone
• Format: Article
• Language: English
• Published: MDPI AG 2019-06-01
• Series: Clinics and Practice
• Subjects: Immunodeficiency; Thymomas; Good’s syndrome; Hypogammaglobulinemia; Infections
• Online Access: https://www.clinicsandpractice.org/index.php/cp/article/view/1112

Good’s syndrome (GS) or thymomaassociated immunodeficiency is a rare clinical entity that should be ruled out in patients with thymoma who develop severe, recurrent bacterial infections and opportunistic viral and fungal infections. There are no treatment protocols established, hence, early recognition is imperative to avoid complications. We report the case of a 42-year-old female, known for a previous thymectomy for giant thymoma who has suffered for a long time from recurrent pulmonary and urinary tract infections and cold sores. In March 2016 she referred to our unit complaining of fever, cough, chest pain, and cold sores due to Herpes simplex virus (HSV), confirmed serologically as HSV-1. Chest X-ray showed left pneumonia due to Streptococcus pneumoniae. She started antibiotics (amoxicillin/clavulanic acid associated with azithromycin) with gradual improvement. Given her history she was studied for an underlying immunodeficiency: IgG, IgA, and IgM were significantly low or absent, as well as all IgG subclasses; blood and bone marrow aspirate leucocyte immunophenotyping showed complete absence of B lymphocytes and reduced CD4+ T cells. In light of: i) thymoma; ii) B lymphocyte deficit; iii) hypogammaglobulinemia; iv) recurrent infections, GS was diagnosed and pre-emptive immunoglobulin treatment, associated with HSV and Pneumocystis jiroveci prophylaxis (Acyclovir for HSV and Sulfamethoxazole- Trimethoprim for P. jiroveci) were started. Since then the patient has no longer presented any infectious episodes.